Weekly paclitaxel plus cetuximab reduces the lung metastasis of adenoid cystic carcinoma arising from the salivary gland

Y Yoshioka, S Toratani, H Nakatao… - Oral Science …, 2015 - Wiley Online Library
Adenoid cystic carcinoma (ACC) of the salivary gland often metastasizes to the lungs. It has
previously been reported that the combination chemotherapy of weekly paclitaxel plus …

Successful treatment with definitive concurrent chemoradiotherapy followed by durvalumab maintenance therapy in a patient with tracheal adenoid cystic carcinoma

E Mikami, S Nakamichi, A Nagano, K Misawa… - Internal …, 2023 - jstage.jst.go.jp
Adenoid cystic carcinoma (ACC) is a rare type of malignant tracheal tumor originating from
the secretory glands. Complete surgical resection is the current standard of care for tracheal …

Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies

RL Dodd, NJ Slevin - Oral oncology, 2006 - Elsevier
Adenoid cystic carcinoma (ACC) accounts for about 1% of all head and neck malignancies.
It has a tendency for a prolonged clinical course, with local recurrences and distant …

MYB rearrangement and clinicopathologic characteristics in head and neck adenoid cystic carcinoma

EM Rettig, M Tan, S Ling, R Yonescu… - The …, 2015 - Wiley Online Library
Objectives Salivary gland adenoid cystic carcinoma (ACC) is rare, aggressive, and
challenging to treat. Many ACCs have at (6; 9) chromosomal translocation resulting in a …

Low‑dose radiotherapy combined with immunotherapy for suboral adenoid cystic carcinoma with bilateral lung metastasis: A case report and literature review

D Li, X Pang, X Zhu, Q Shanzhou… - Oncology …, 2022 - spandidos-publications.com
Adenoid cystic carcinoma (ACC) is a type of malignant tumor arising from the salivary
glands. The tumor is characterized by a predilection for recurrence and metastasis. At …

Adenoid cystic carcinoma of base of tongue

A Akhavan, H Navabii, M Saeb - Case Reports, 2012 - casereports.bmj.com
Adenoid cystic carcinoma (ACC) is a rare malignant tumour arising from salivary glands.
ACC of the head and neck shows a long natural course, high recurrence rates, late …

Relapsed acinic cell carcinoma of the parotid gland with diffuse distant metastasis: case report with literature review

Y Khelfa, M Mansour, Y Abdel-Aziz… - … High Impact Case …, 2016 - journals.sagepub.com
Acinic cell carcinoma (ACC) is an uncommon salivary gland neoplasm that generally
displays an indolent growth pattern. Most cases arise in the major glands, particularly the …

A phase II study of lenvatinib plus pembrolizumab in patients with progressive, recurrent/metastatic adenoid cystic carcinoma.

M Mohamadpour, EJ Sherman, A Kriplani, JV Fetten… - 2023 - ascopubs.org
6048 Background: Recurrent/metastatic adenoid cystic carcinoma (R/M ACC) is a rare
salivary gland cancer (SGC) without standard treatments. The multitargeted, antiangiogenic …

Clinical outcomes and prognostic factors of adenoid cystic carcinoma of the head and neck

S Jang, PN Patel, RJ Kimple… - Anticancer research, 2017 - ar.iiarjournals.org
Background: Adenoid cystic carcinoma (ACC) is a salivary gland malignancy with
unpredictable growth and poorly understood prognostic factors. Patients and Methods: A …

[HTML][HTML] A phase II study of sunitinib in recurrent and/or metastatic adenoid cystic carcinoma (ACC) of the salivary glands: current progress and challenges in …

NG Chau, SJ Hotte, EX Chen, SF Chin, S Turner… - Annals of oncology, 2012 - Elsevier
Background Vascular endothelial growth factor (VEGF) and c-kit are highly expressed in
adenoid cystic carcinoma (ACC) and associated with biologic aggressiveness. This study …